OSETRON 8 MG/4 ML IM/IV INJECTION SOLUTION IN 1 AMPULE – What is it, Uses & 2026 Price in Turkey

by

Clinical Data Review: Comprehensive profile for OSETRON 8 MG/4 ML IM/IV INJECTION SOLUTION IN 1 AMPULE, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: OSETRON 8 MG/4 ML IM/IV INJECTION SOLUTION IN 1 AMPULE

Manufacturer: HAVER PHARMACY PHARMACEUTICALS INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

ONDANSETRON 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

OSETRON 8 MG/4 ML IM/IV INJECTION SOLUTION IN 1 AMPULE is formulated with ONDANSETRON, a clinically established agent in medical practice.

  • Mechanism of Action: ONDANSETRON acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to ONDANSETRON therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name OSETRON 8 MG/4 ML IM/IV INJECTION SOLUTION IN 1 AMPULE
Barcode (GTIN) 8680400770394
Generic Name ONDANSETRON
License Holder HAVER PHARMACY PHARMACEUTICALS INC.
Pharmacy Retail Price 223.56 TL
⚠️ Clinical Safety Warning

Do not administer OSETRON 8 MG/4 ML IM/IV INJECTION SOLUTION IN 1 AMPULE if the patient has a known hypersensitivity or allergy to ONDANSETRON. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via HAVER PHARMACY PHARMACEUTICALS INC..

Leave a Comment